- Home
- MAMA vs ITOS Comparison
MAMA vs ITOS Comparison
Compare MAMA & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAMA
- ITOS
- Stock Information
- Founded
- MAMA 2010
- ITOS 2011
- Country
- MAMA United States
- ITOS United States
- Employees
- MAMA N/A
- ITOS N/A
- Industry
- MAMA Specialty Foods
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MAMA Consumer Staples
- ITOS Health Care
- Exchange
- MAMA Nasdaq
- ITOS Nasdaq
- Market Cap
- MAMA 290.7M
- ITOS 271.1M
- IPO Year
- MAMA N/A
- ITOS 2020
- Fundamental
- Price
- MAMA $7.67
- ITOS $7.90
- Analyst Decision
- MAMA Strong Buy
- ITOS Strong Buy
- Analyst Count
- MAMA 3
- ITOS 3
- Target Price
- MAMA $10.67
- ITOS $21.33
- AVG Volume (30 Days)
- MAMA 473.3K
- ITOS 522.9K
- Earning Date
- MAMA 12-16-2024
- ITOS 11-12-2024
- Dividend Yield
- MAMA N/A
- ITOS N/A
- EPS Growth
- MAMA N/A
- ITOS N/A
- EPS
- MAMA 0.08
- ITOS N/A
- Revenue
- MAMA $116,468,000.00
- ITOS $35,000,000.00
- Revenue This Year
- MAMA $18.91
- ITOS $271.18
- Revenue Next Year
- MAMA $12.69
- ITOS N/A
- P/E Ratio
- MAMA $91.21
- ITOS N/A
- Revenue Growth
- MAMA 17.20
- ITOS N/A
- 52 Week Low
- MAMA $4.17
- ITOS $7.09
- 52 Week High
- MAMA $9.98
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- MAMA 39.03
- ITOS 50.20
- Support Level
- MAMA $7.55
- ITOS $7.17
- Resistance Level
- MAMA $9.83
- ITOS $7.51
- Average True Range (ATR)
- MAMA 0.46
- ITOS 0.36
- MACD
- MAMA -0.11
- ITOS 0.06
- Stochastic Oscillator
- MAMA 17.27
- ITOS 61.36
About MAMA Mama's Creations Inc.
Mama`s Creations Inc is a marketer and manufacturer of fresh deli-prepared foods, found in over 8,400 grocery, mass, club, and convenience stores nationally. The company's broad product portfolio, born from a rich history in Italian foods, now consists of a variety of high-quality, fresh, clean, and easy-to-prepare foods to address the needs of both consumers and retailers.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.